Prime Factors' wrote a check that Voyager's episodic nature could rarely cash–but it was still worth writing anyway.

The decision comes as the Voyager spacecraft face diminishing power supplies due to the gradual decay of their radioactive ...

Voyager Therapeutics (VYGR) reported new data from its two preclinical programs targeting tau for the treatment of Alzheimer’s disease. Data on ...

An analysis of two decades of data from NASA's Hubble Space Telescope has provided fresh insights into the complex ...

Portland-based Sturdy.ai, a startup whose platform uses AI to analyze customer communications across multiple channels to ...

Voyager episodes hint at the amazing and much stronger character Kes could've been if Jennifer Lien hadn't left in season 4.

What can a sample return mission from Jupiter's volcanic moon, Io, teach scientists about planetary and satellite (moon) formation and evolution? This is what a recent study presented at the 56th ...

Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and liver de-targeting, in NHP study - - Preclinical muri ...

Voyager season 4 introduced one of Star Trek's most iconic characters, and these 10 episodes show how the season was a change ...

Voyager Midstream Holdings (Voyager), a portfolio company of Pearl Energy Investments, has completed the acquisition of a non ...

However, no missions capture the power of RTGs quite like the Voyager missions. NASA launched the twin spacecraft Voyager 1 ...

Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have been given an average rating of “Buy” by the nine analysts that are covering the company, Marketbeat.com reports. Eight ...